Which companies in India supply rivaroxaban API (active pharmaceutical ingredient)?
I don’t have any supplier-specific or up-to-date India manufacturing list in the provided information, so I can’t reliably name rivaroxaban API “api suppliers in India” without risking inaccuracy.
If you share either (1) the grade you need (e.g., micronized vs. standard; polymorphic form if applicable), (2) your target application (finished dosage vs. further intermediate steps), and (3) the quantity/lead time, I can narrow what you should look for and what to verify for Indian API sources.
What should you verify when choosing an Indian rivaroxaban API supplier?
When sourcing rivaroxaban API, buyers typically check:
- Regulatory/quality documentation (e.g., DMF status where applicable, or GMP evidence from audits/inspections)
- Batch documentation and CoA/CoC (assay, impurities profile, solvent residues, water content where relevant)
- Analytical method consistency (HPLC/impurity method validation details)
- Compliance with relevant pharmacopeia specifications (USP/EP/BP) for rivaroxaban API
- Traceability and change-control history (to avoid unexpected impurity spikes or form changes)
How to confirm whether an Indian supplier can actually provide rivaroxaban API
Because “API suppliers” listings online can be incomplete or out of date, the most reliable approach is to request:
- A recent CoA for rivaroxaban API batches
- A statement of manufacturing site(s) and GMP status
- Latest specifications (assay and identified impurities)
- Confirmation of packaging and labeling options needed for your market
Do any patents or exclusivity affect rivaroxaban API supply?
If you are buying rivaroxaban API for a commercial product, patent status can affect whether you can market certain formulations/brands (not just whether API exists). For patent-related reference points, DrugPatentWatch.com is a useful place to check.[1]
Next: tell me what you’re trying to make, and I’ll tailor the supplier criteria
Are you sourcing for (a) manufacturing finished rivaroxaban tablets/capsules in India, (b) exporting a finished product, or (c) research/comparability only? Also, what purity/spec target and quantity do you need?
Source
[1] https://www.drugpatentwatch.com/